RSPO3 and cancer: Together with its ligand RSPO3, the LGR5 receptor promotes β-catenin signaling in cancer cells predominantly via membrane clearance of two endogenous negative regulators of β-catenin signaling: the transmembrane ubiquitin ligases ZNRF3 and RNF43 [17,21,31].